WebApr 21, 2024 · Cancer cells can survive chemotherapy-induced stress, but how they recover from it is not known. Using a temporal multiomics approach, we delineate... WebOct 1, 2024 · Dysregulated lipid metabolism is a prominent feature of prostate cancer that is driven by androgen receptor (AR) signaling. Here we used quantitative mass spectrometry to define the “lipidome” in prostate tumors with matched benign tissues (n = 21), independent unmatched tissues (n = 47), and primary prostate explants cultured with the …
Lipid-Based Drug Delivery Systems in Cancer Therapy: What Is
WebApr 22, 2024 · Cell heterogeneity of tumor tissues is one of the causes of cancer recurrence after chemotherapy. Cell subtype identification in tumor tissues of specific cancer is critical for precision medicine and prognosis. As the structural and functional components of cells, lipids are closely related to the apparent morphology of cells. WebJan 3, 2024 · Genome-wide expression profiling identifies a novel 9-miRNA panel for predicting response to systemic chemotherapy We analyzed sequencing-based miRNA expression profiling data from patients with mGC. Blood samples were prospectively collected from patients visiting the City of Hope Comprehensive Cancer Center, Duarte, … self topic
Prediction of response and adverse drug reaction of pemetrexed …
WebJan 15, 2024 · Here, we show that a “surge” or series of proinflammatory cytokines and bioactive lipids induced by chemotherapy-generated tumor cell debris is suppressed by … WebJan 10, 2024 · Figure 1 Adjuvant chemotherapy cohort and regions captured by Nanostring GeoMX Digital Spatial Profiling protein assay.(A) Kaplan-Meier survival curve of TNBC cohort which consisted of 15 patients who responded to chemotherapy (red line) and 9 patients who relapsed and succumbed to disease within follow-up time (blue line).(B, C) … WebThe prevalence of dyslipidemia in patients stratified by BMI varied from 15.0% to 55.4%. Chemotherapy had a dramatic effect on the blood lipid levels of breast cancer patients with low-weight (BMI<18 kg/m 2 ), with the dyslipidemia rate rising sharply from 15.0% before chemotherapy to 55.0% ( P <0.05) at the 1st month after chemotherapy. self torino orari